Jacob Ipsen, Project Manager of Novo Nordisk Kalundborg Danmark

Jacob Ipsen, Project Manager of Novo Nordisk Kalundborg Danm

点击数:166 发布时间:2019-07-02
Jacob Ipsen, Project Manager of Novo Nordisk Kalundborg Danm

PMOffice_Visitkort041 副本.jpg

Jacob Ipsen, Project Manager of Novo Nordisk Kalundborg Danmark

 

Bachelor of science within engineering in DK;

Certified graduate project manager from US;

20+ years of experiance within establishment of Pharmaceutical & Biotechnology facilities from Conceptual Design to Production;

20+ years of experience within project management,  commissioning, construction and EHS management; 

7 + years experience previously in China working with construction and project management;

As an employee in Novo Nordisk, Jacob is at present working as Project Manager for a substantial upgrade project of an insulin purification factory in Kalundborg Denmark;

As a person with a wide interdisciplinary knowledge and comprehensive practical experience, who can take a leading role from the design phase through commissioning until hand-over of the project;

His personal profile characterise him as a multi skilled individual who thinks outside the box.  A positive thinking, pro-active team player who has a strong willed perseverance to achieve the goal set;

Experience gained whilst working with various nationalities abroad has ensured a high level of adaptation, acceptance and understanding. He is a person with an enthusiastic personality who appreciates interacting with other people.

 

2015-Now Project Manager, Novo Nordisk A/S, Denmark;

2013-2015 Senior Project Manager, Rambøll A/S, Denmark;

2011-2013 Senior Project Manager, NNE Pharmaplan A/S, Denmark;

2006-2010 Senior Project Manager, NNE Pharmaplan A/S, China;

2005-2006 Construction Manager, NNE Pharmaplan A/S, China;

2002-2005 Construction Manager, NNE Pharmaplan A/S, Denmark;

1999-2002 Project Manager, Novo Nordisk A/S, Denmark;

1994-1999 Commissioning Engineer/Lead, FLS Miljo A/S, Denmark;

1992-1994 Marine Engineer, EAC, Denmark.